Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Cancer|February 1, 1989
Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaS Huan, R Pazdur, A Singhakowinta, et al.
Seminars in Oncology|December 22, 1999
Oral fluoropoyrimidinesP M Hoff, M Royce, D Medgyesy, et al.
Oncology (Williston Park, N.Y.)|November 27, 1998
The oral fluorouracil prodrugsR Pazdur, P M Hoff, D Medgyesy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Multiple primary malignanciesR S Hoffman, A H Rossof, R Pazdur, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
American Journal of Clinical Oncology|December 1, 1989
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinomaP LoRusso, R Pazdur, B G Redman, et al.
Cancer Treatment Reports|December 1, 1986
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinomaP D Bonomi, R Pazdur, L Stolbach, et al.
Anti-Cancer Drugs|September 1, 1996
Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicitiesR Pazdur, Y Lassere, E Diaz-Canton, et al.
Cancer|February 1, 1989
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesisC J Gordon, R Pazdur, A Ziccarelli, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 7, 1999
Effects of age on balance assessment using voluntary and involuntary step tasksC W Luchies, D Wallace, R Pazdur, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Cancer|February 1, 1989
Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinomaS Huan, R Pazdur, A Singhakowinta, et al.
Seminars in Oncology|December 22, 1999
Oral fluoropoyrimidinesP M Hoff, M Royce, D Medgyesy, et al.
Oncology (Williston Park, N.Y.)|November 27, 1998
The oral fluorouracil prodrugsR Pazdur, P M Hoff, D Medgyesy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Multiple primary malignanciesR S Hoffman, A H Rossof, R Pazdur, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
American Journal of Clinical Oncology|December 1, 1989
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinomaP LoRusso, R Pazdur, B G Redman, et al.
Cancer Treatment Reports|December 1, 1986
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinomaP D Bonomi, R Pazdur, L Stolbach, et al.
Anti-Cancer Drugs|September 1, 1996
Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicitiesR Pazdur, Y Lassere, E Diaz-Canton, et al.
Cancer|February 1, 1989
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesisC J Gordon, R Pazdur, A Ziccarelli, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 7, 1999
Effects of age on balance assessment using voluntary and involuntary step tasksC W Luchies, D Wallace, R Pazdur, et al.
Pageof 16